The US Food and Drug Administration’s (FDA) interest in rooting out data integrity deficiencies among Indian pharmaceutical manufacturers continued this month with a warning letter issued to Hyderabad ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results